95
Views
24
CrossRef citations to date
0
Altmetric
Review

Thinking beyond low-density lipoprotein cholesterol: strategies to further reduce cardiovascular risk

, &
Pages 793-799 | Published online: 21 Sep 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mahfouz Al-Bachir & Mohamad Adel Bakir. (2016) Correlation between fat mass estimated by skin-fold thickness and blood pressure and serum biomarker in Syrian adolescents. International Journal of Health Promotion and Education 54:2, pages 72-81.
Read now

Articles from other publishers (23)

Marcello Nicoletti. 2022. The Pharmacological Potential of Cyanobacteria. The Pharmacological Potential of Cyanobacteria 287 330 .
Rehab Ibrahim Yaseen, Mohamed Hesham El-Leboudy & Hend Mohammed El-Deeb. (2021) The relation between ApoB/ApoA-1 ratio and the severity of coronary artery disease in patients with acute coronary syndrome. The Egyptian Heart Journal 73:1.
Crossref
K. Dhandayuthapani, S. Malathy, Sikandar I. Mulla & Sanjay Kumar Gupta. 2021. Algae. Algae 135 179 .
Mahfouz Al-Bachir & Mohamad Adel Bakir. (2017) Predictive value of body mass index to metabolic syndrome risk factors in Syrian adolescents. Journal of Medical Case Reports 11:1.
Crossref
Naoyuki Kitao, Hideaki Miyoshi, Tomoo Furumoto, Kota Ono, Hiroshi Nomoto, Aika Miya, Chiho Yamamoto, Atsushi Inoue, Kenichi Tsuchida, Naoki Manda, Yoshio Kurihara, Shin Aoki, Akinobu Nakamura & Tatsuya Atsumi. (2017) The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3). Cardiovascular Diabetology 16:1.
Crossref
Javier Rodríguez-Carrio, Mercedes Alperi-López, Patricia López, Raquel López-Mejías, Sara Alonso-Castro, Francisco Abal, Francisco J. Ballina-García, Miguel Á. González-Gay & Ana Suárez. (2017) High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein. Journal of Clinical Lipidology 11:4, pages 1043-1054.e2.
Crossref
Tina Heinz, Jan Philipp Schuchardt, Katharina Möller, Peyman Hadji & Andreas Hahn. (2016) Low daily dose of 3 mg monacolin K from RYR reduces the concentration of LDL-C in a randomized, placebo-controlled intervention. Nutrition Research 36:10, pages 1162-1170.
Crossref
Chao Zhao, Yijing Wu, Chengfeng Yang, Bin Liu & Yifan Huang. (2015) Hypotensive, hypoglycaemic and hypolipidaemic effects of bioactive compounds from microalgae and marine micro-organisms. International Journal of Food Science & Technology 50:8, pages 1705-1717.
Crossref
Karl-Heinz Wagner, Marlies Wallner, Christine Mölzer, Silvia Gazzin, Andrew Cameron Bulmer, Claudio Tiribelli & Libor Vitek. (2015) Looking to the horizon: the role of bilirubin in the development and prevention of age-related chronic diseases. Clinical Science 129:1, pages 1-25.
Crossref
Seemadevi Patil, Prabhakaran J, Sheena Nazar & Abaya K. (2015) TO STUDY ASSOCIATION BETWEEN LIPID PROFILE IN VEGETARIANS AND NON - VEGETARIANS IN THE LOCAL POPULATION. Journal of Evolution of Medical and Dental Sciences 4:32, pages 5533-5537.
Crossref
Wan Nor Hanis Wan Ahmad, Farah Sakri, Atiqah Mokhsin, Thuhairah Rahman, Nadzimah Mohd Nasir, Suraya Abdul-Razak, Mazapuspavina Md Yasin, Aletza Mohd Ismail, Zaliha Ismail & Hapizah Nawawi. (2015) Low Serum High Density Lipoprotein Cholesterol Concentration is an Independent Predictor for Enhanced Inflammation and Endothelial Activation. PLOS ONE 10:1, pages e0116867.
Crossref
Yi Zhang, Jack W Kent, Adam Lee, Diana Cerjak, Omar Ali, Robert Diasio, Michael Olivier, John Blangero, Melanie A Carless & Ahmed H Kissebah. (2013) Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a northern european family population. BMC Medical Genomics 6:1.
Crossref
Filipa Mascarenhas-Melo, Daniela Marado, Filipe Palavra, José Sereno, Álvaro Coelho, Rui Pinto, Edite Teixeira-Lemos, Frederico Teixeira & Flávio Reis. (2013) Diabetes abrogates sex differences and aggravates cardiometabolic risk in postmenopausal women. Cardiovascular Diabetology 12:1.
Crossref
Ángel Díaz Rodríguez, Adalberto Serrano Cumplido, David Fierro González, Luis Alberto Rodríguez Arroyo, Francisco-Javier García-Norro Herreros, Serafín de Abajo Olea, Isidro López Rodríguez, Josefa María Panisello Royo, Jose Carlos Minguez Villar, Jesús Palomo del Arco, Rafael Colás Chacartegui, Vicente Pascual Fuster & Juan Carlos Verdes-Montenegro Atalaya. (2012) Pitavastatina: una nueva alternativa en el tratamiento de la dislipemia. Clínica e Investigación en Arteriosclerosis 24:1, pages 30-39.
Crossref
Elena V. Kuklina, Nora L. Keenan, William M. Callaghan & Yuling Hong. (2011) Risk of Cardiovascular Mortality in Relation to Optimal Low-Density Lipoprotein Cholesterol Combined with Hypertriglyceridemia: Is There a Difference by Gender?. Annals of Epidemiology 21:11, pages 807-814.
Crossref
Alan J. Garber. (2011) Focus on Incretin-Based Therapies for Patients with Type 2 Diabetes and Cardiovascular Disease. Endocrine Practice 17, pages 13-19.
Crossref
Min Lu, Qun Lu, Yong Zhang & Gang Tian. (2011) ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity. Journal of Biomedical Research 25:4, pages 266-273.
Crossref
Elena V. KuklinaBrian T. Bateman. (2011) Pregnancy Complications and Prevention of Cardiovascular Disease in Women: Stay Tuned. Journal of Women's Health 20:5, pages 657-659.
Crossref
Leiv Ose. (2011) Pitavastatin: finding its place in therapy. Therapeutic Advances in Chronic Disease 2:2, pages 101-117.
Crossref
Akira Takaki, Seiji Umemoto, Kaoru Ono, Kouzaburo Seki, Tsutomu Ryoke, Akihisa Fujii, Tatsunori Itagaki, Masahiko Harada, Masakazu Tanaka, Takahito Yonezawa, Hiroshi Ogawa & Masunori Matsuzaki. (2011) Add-on Therapy of EPA Reduces Oxidative Stress and Inhibits the Progression of Aortic Stiffness in Patients with Coronary Artery Disease and Statin Therapy: A Randomized Controlled Study. Journal of Atherosclerosis and Thrombosis 18:10, pages 857-866.
Crossref
George L. Blackburn, Kristina Spellman & Samuel Wollner. 2011. Preventive Cardiology: Companion to Braunwald's Heart Disease. Preventive Cardiology: Companion to Braunwald's Heart Disease 317 330 .
Luís Masana. (2010) Pitavastatin – from clinical trials to clinical practice. Atherosclerosis Supplements 11:3, pages 15-22.
Crossref
Ruitang Deng & Te-Jin Chow. (2010) Hypolipidemic, Antioxidant, and Antiinflammatory Activities of Microalgae Spirulina. Cardiovascular Therapeutics 28:4, pages e33-e45.
Crossref